(function(){var loadHandler=window['sl_{E3D701B7-9456-41DA-AA5D-ED55FDEB2C76}'];loadHandler&&loadHandler(1, '<div id="spr0_347ecf24"><div id="spr1_347ecf24" class="kern slide"><img id="img6_347ecf24" src="data/img1.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_347ecf24" class="kern slide"><img id="img0_347ecf24" src="data/img2.png" width="721.48" height="100.8" alt="" style="left:-1.48px;"/><div id="svg1_347ecf24" style="left:-1.48px;top:99.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#c76c02" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><div id="svg2_347ecf24" style="left:-1.48px;top:0.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#2e3546" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><img id="img1_347ecf24" src="data/img3.png" width="721.48" height="43.101" alt="" style="top:496.899px;"/><div id="spr3_347ecf24" style="left:657.715px;top:499.855px;"><img id="img2_347ecf24" src="data/img4.png" width="56" height="36" alt="CHRC logo_with text.psd" style="left:-0.105px;top:-0.177px;"/></div><div id="spr4_347ecf24" style="left:-1.48px;top:7.99px;"><div style="width:0px;"><span id="txt0_347ecf24" data-width="513.312500" style="left:103.435px;top:5.086px;"> 2016 CCS Lipid Guidelines Recommend:</span></div><div style="width:0px;"><span id="txt1_347ecf24" data-width="695.453125" style="left:13.335px;top:43.486px;">Targeting Lower LDL-C to Lower the Risk for CV Events</span></div></div><div id="spr5_347ecf24" style="left:6.496px;top:507.023px;"><div style="width:0px;"><span id="txt2_347ecf24" class="nokern" data-width="125.978027" style="left:7.2px;top:4.096px;">Anderson TJ et al. 2016;32:1263-1282</span></div></div><div id="spr6_347ecf24" style="left:378px;top:152.54px;"><img id="img3_347ecf24" src="data/img5.png" width="326.38" height="257.474" alt=""/></div><div id="spr7_347ecf24" style="left:24.624px;top:152.54px;"><img id="img4_347ecf24" src="data/img5.png" width="326.38" height="257.474" alt=""/></div><div id="spr8_347ecf24" style="left:19.805px;top:164.544px;"><div style="width:0px;"><span id="txt3_347ecf24" data-width="189.472656" style="left:69.38px;top:6.231px;">TREATMENT TARGETS:</span></div></div><div id="spr9_347ecf24" style="left:40.044px;top:200.595px;"><div style="width:0px;"><span id="txt4_347ecf24" class="nokern relpos" style="left:14.756px;top:12.561px;"></span><span id="txt5_347ecf24" class="relpos" data-width="226.845703" style="left:29.021px;top:12.148px;">LDL-C consistently &lt;2.0 mmol/L or</span></div><div style="width:0px;"><span id="txt6_347ecf24" data-width="102.990234" style="left:37.256px;top:33.748px;">&gt;50% reduction</span></div><div style="width:0px;"><span id="txt7_347ecf24" class="nokern relpos" style="left:14.756px;top:65.761px;"></span><span id="txt8_347ecf24" class="relpos" data-width="246.559570" style="left:29.021px;top:65.348px;">Consider &lt;1.8 mmol/L in patients with</span></div><div style="width:0px;"><span id="txt9_347ecf24" data-width="147.673828" style="left:37.256px;top:86.948px;">clinical atherosclerosis</span></div><div style="width:0px;"><span id="txt10_347ecf24" class="nokern relpos" style="left:14.756px;top:118.961px;"></span><span id="txt11_347ecf24" class="relpos" data-width="238.007813" style="left:29.021px;top:118.548px;">Apo B ≤0.80 g/L or non-HDL-C ≤2.6</span></div><div style="width:0px;"><span id="txt12_347ecf24" data-width="192.832031" style="left:37.256px;top:140.148px;">mmol/L can be considered as</span></div><div style="width:0px;"><span id="txt13_347ecf24" data-width="183.805664" style="left:37.256px;top:161.748px;">alternative treatment targets</span></div></div><div id="spr10_347ecf24" style="left:374.311px;top:160.52px;"><div style="width:0px;"><span id="txt14_347ecf24" data-width="260.537109" style="left:35.181px;top:6.231px;">STATIN INDICATED CONDITIONS</span></div></div><div id="spr11_347ecf24" style="left:392.333px;top:220.11px;"><div style="width:0px;"><span id="txt15_347ecf24" class="nokern relpos" style="left:13.781px;top:11.586px;"></span><span id="txt16_347ecf24" class="relpos" data-width="156.682617" style="left:28.046px;top:11.173px;">Clinical atherosclerosis*</span></div><div style="width:0px;"><span id="txt17_347ecf24" class="nokern relpos" style="left:13.781px;top:43.186px;"></span><span id="txt18_347ecf24" class="relpos" data-width="178.857422" style="left:28.046px;top:42.773px;">Abdominal aortic aneurysm</span></div><div style="width:0px;"><span id="txt19_347ecf24" class="nokern relpos" style="left:13.781px;top:74.786px;"></span><span id="txt20_347ecf24" class="relpos" data-width="146.047852" style="left:28.046px;top:74.373px;">Most diabetes mellitus</span></div><div style="width:0px;"><span id="txt21_347ecf24" class="nokern relpos" style="left:13.781px;top:106.386px;"></span><span id="txt22_347ecf24" class="relpos" data-width="139.051758" style="left:28.046px;top:105.973px;">CKD (age &gt;50 years)</span></div><div style="width:0px;"><span id="txt23_347ecf24" class="nokern relpos" style="left:13.781px;top:137.986px;"></span><span id="txt24_347ecf24" class="relpos" data-width="129.638672" style="left:28.046px;top:137.573px;">LDL-C ≥5.0 mmol/L</span></div></div><div id="spr12_347ecf24" style="left:371.818px;top:189.97px;"><div style="width:0px;"><span id="txt25_347ecf24" data-width="191.078125" style="left:68.568px;top:5.921px;">(those who will benefit the most):</span></div></div><div id="spr13_347ecf24" style="left:16.104px;top:417.223px;"><div style="width:0px;"><span id="txt26_347ecf24" data-width="645.416016" style="left:7.2px;top:1.545px;">*Clinical atherosclerosis, i.e., previous MI, or coronary revascularization by PCI or CABG surgery, other arterial revascularization procedures, angina</span></div><div style="width:0px;"><span id="txt27_347ecf24" data-width="469.066406" style="left:7.2px;top:15.945px;">pectoris, cerebrovascular disease including TIA, or peripheral arterial disease (claudication and/or ABI &lt;0.9)</span></div><div style="width:0px;"><span id="txt28_347ecf24" data-width="654.732422" style="left:7.2px;top:30.345px;">ABI, ankle brachial index; Apo B, apolipoprotein B; CABG, coronary artery bypass graft surgery; CCS, Canadian Cardiovascular Society; CKD, chronic</span></div><div style="width:0px;"><span id="txt29_347ecf24" data-width="669.474609" style="left:7.2px;top:44.745px;">kidney disease; CV, cardiovascular; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; PCI,</span></div><div style="width:0px;"><span id="txt30_347ecf24" data-width="291.023438" style="left:7.2px;top:59.145px;">percutaneous coronary intervention; TIA, transient ischemic attack.</span></div></div><div id="spr14_347ecf24" style="left:24.624px;top:105.301px;"><img id="img5_347ecf24" src="data/img6.png" width="116" height="37" alt="" style="left:0.123px;top:0.198px;"/></div></div></div>');})();